In gliomas, our data showed that EFEMP1 binding to EGFR blocked EGF-mediated activation of PI3K and MAPK signaling pathways (Figures 4), while in pancreatic carcinoma cells it was shown to promote these activities [24]. This evidence concerns the gene EGFR and exocrine pancreatic carcinoma.